Promethazine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Promethazine Hydrochloride Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Nov 21, 2023. Reported reason: Demand increase for the drug
Shortage details
- Status
- Current
- Company
- Hikma Pharmaceuticals USA, Inc.
- Package NDC
- 0641-1495-35
- Dosage Form
- Injection
- Presentation
- Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-1495-35)
- Initial Posting
- Nov 21, 2023
Reason
Demand increase for the drug